Monitor whether the $93.3 million in proceeds is used to fund the previously announced acquisition of bota-vec from Johnson & Johnson, as the timing suggests a connection between these transactions.
Price Chart
Executive Summary
MeiraGTx Holdings plc (MGTX) entered into an underwriting agreement to sell 11,111,111 ordinary shares at $9.00 per share, raising approximately $93.3 million in net proceeds. The capital raise occurred within 14 days of a prior acquisition agreement, suggesting the funds may be financing the reacquisition of the gene therapy candidate bota-vec from Johnson & Johnson.
Key Financial Metrics
Key Facts
- MeiraGTx entered into an underwriting agreement to issue 11,111,111 ordinary shares
- Offering price is $9.00 per share, with net proceeds estimated at $93.3 million
- Proceeds will be used for general corporate purposes including working capital and capital expenditures
- The capital raise occurred on the same day as a prior acquisition filing, suggesting potential financing connection
Financial Impact
Raises approximately $93.3 million in net proceeds through the issuance of 11,111,111 shares
Risk Factors
- Dilution to existing shareholders from the issuance of new shares
- Uncertainty about how the proceeds will be allocated among various corporate purposes
- Potential for the capital raise to be used for the acquisition, which could impact financial stability
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (MGTX) — Batch item 1 | 0001104659-26-044462 |
| Document: tm2611992d1_8k.htm | 0001104659-26-044464 |
| Document: tm2611992d1_ex5-1.htm | 0001104659-26-044462 |
| Document: 0001104659-26-044462-index-headers.html | 0001104659-26-044462 |
| Document: 0001104659-26-044462-index.html | 0001104659-26-044462 |
| Document: 0001104659-26-044462.txt | 0001104659-26-044462 |
| 424B5 Filing (MGTX) — Batch item 7 | 0001104659-26-044464 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 20d ago | 144 | $10.82 | awaiting T+60 | — | $9.40 (−13.12%) |
Sep 24, 2026 4w ago | 3 | $10.91 | awaiting T+60 | — | $9.40 (−13.84%) |
Sep 23, 2026 4w ago | 8-K | $11.75 | awaiting T+60 | — | $9.40 (−20.00%) |
Aug 18, 2026 9w ago | 144 | $14.97 | awaiting T+60 | — | $9.40 (−37.21%) |
Aug 13, 2026 10w ago | 8-K | $12.67 | awaiting T+60 | — | $9.40 (−25.81%) |
Aug 13, 2026 10w ago | Press Release | $12.67 | awaiting T+60 | — | $9.40 (−25.81%) |
Jul 7, 2026 16w ago | 8-K | $14.66 $11.00 | ▼ −24.97% | ▼ −26.96% | $9.40 (−35.88%) |
May 19, 2026 22w ago | 144 | $9.58 $13.52 | ▲ +41.13% | ▲ +36.12% | $9.40 (−1.88%) |
May 14, 2026 23w ago | 8-K | $9.95 $13.02 | ▲ +30.85% | ▲ +27.27% | $9.40 (−5.53%) |
May 14, 2026 23w ago | Press Release | $9.95 $13.02 | ▲ +30.85% | ▲ +27.27% | $9.40 (−5.53%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers